Position in ANNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,039,945
+$931,816 QoQ
Shares Held
3,509,623
+1.8% QoQ
Ownership
1.72%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#15
of 216 holders
Holding Since
Sep 2020
10 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. ANNX ranks #34 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in ANNX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,039,945 | 3,509,623 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $19,108,129 | 3,449,121 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $21,830,885 | 4,348,782 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $6,686,679 | 2,192,354 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,198,827 | 2,166,178 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $7,691,619 | 3,985,295 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,753,672 | 926,642 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $939,935 | 158,773 | Shares | Defined | 2024-11-14 | |
| 2020-12-31 | $6,184,187 | 247,071 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,063,563 | 200,581 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||